Johnson & Johnson (JNJ)
$261.44+1.93%Close
SELLBEAR · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV9.3%–45.0%
- Market cap
- $630.0B
- Beta
- 0.23
- Div yield
- 2.07%
- P/E (TTM)
- 29.45
- IV-%ile
- 90
- IV ATM
- 30.6%
- Short % float
- 0.92%
- Days to cover
- 3.3
- SI change
- +4.2%
- 1W
- +2.11%
- 1M
- -1.84%
- vs SPY 1W
- +0.95%
- vs SPY 1M
- -4.84%
Industry peers
FMP comparable companies · ranked by market cap
- ABBVBUYAbbVie Inc.$488.5BBULLQ 29$276.47+1.49%
- MRKSELLMerck & Co., Inc.$359.6BBEARQ 11$145.60+2.26%
- NVSBUYNovartis AG$273.2BRECOVERYQ 20$143.75+0.45%
- AZNSELLAstraZeneca PLC$246.9BRECOVERYQ 20$159.20+0.26%
- AMGNBUYAmgen Inc.$223.9BRECOVERYQ 22$414.87+1.82%
- GILDSELLGilead Sciences, Inc.$187.4BBULLQ 25$151.17+2.77%
- PFESELLPfizer Inc.$161.2BBULLQ 13$28.28+1.65%
- BMYSELLBristol-Myers Squibb Company$120.8BBEARQ 10$59.12-0.77%
- SNYSELLSanofi$96.2BBEARQ 11$40.07-0.40%
- GSKSELLGSK plc$93.2BRECOVERYQ 14$46.50-0.09%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on JNJ?
- LOPJLB’s latest quantitative signal on Johnson & Johnson (JNJ) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is JNJ in?
- Johnson & Johnson (JNJ) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Johnson & Johnson (JNJ) do?
- Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes …